BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32829014)

  • 1. Plant natural products as source of new P2 receptors ligands.
    Pacheco PAF; Diogo RT; Magalhães BQ; Faria RX
    Fitoterapia; 2020 Oct; 146():104709. PubMed ID: 32829014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of natural products on p2 receptors: a reinvented era for drug discovery.
    Faria R; Ferreira L; Bezerra R; Frutuoso V; Alves L
    Molecules; 2012 Nov; 17(11):13009-25. PubMed ID: 23117439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2 Receptors Influence hMSCs Differentiation towards Endothelial Cell and Smooth Muscle Cell Lineages.
    Zhang Y; Babczyk P; Pansky A; Kassack MU; Tobiasch E
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adventures in the pharmacological analysis of P2 receptors.
    Fagura MS; Jarvis GE; Dougall IG; Leff P
    J Auton Nerv Syst; 2000 Jul; 81(1-3):178-86. PubMed ID: 10869718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2-pyrimidinergic receptors and their ligands.
    Müller CE
    Curr Pharm Des; 2002; 8(26):2353-69. PubMed ID: 12369950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment.
    Ai X; Dong X; Guo Y; Yang P; Hou Y; Bai J; Zhang S; Wang X
    Purinergic Signal; 2021 Jun; 17(2):229-240. PubMed ID: 33751327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minor contribution of ATP P2 receptors to electrically-evoked electrographic seizure activity in hippocampal slices: Evidence from purine biosensors and P2 receptor agonists and antagonists.
    Lopatář J; Dale N; Frenguelli BG
    Neuropharmacology; 2011; 61(1-2):25-34. PubMed ID: 21338615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
    Yu Y; Zhang C
    Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Therapeutic Applications of P2 Receptor Antagonists: From Bench to Clinical Trials.
    da Silva Ferreira NC; Alves LA; Soares-Bezerra RJ
    Curr Drug Targets; 2019; 20(9):919-937. PubMed ID: 30760187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel P2Y14 agonist and antagonist using conventional and nonconventional methods.
    Hamel M; Henault M; Hyjazie H; Morin N; Bayly C; Skorey K; Therien AG; Mancini J; Brideau C; Kargman S
    J Biomol Screen; 2011 Oct; 16(9):1098-105. PubMed ID: 21821827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2 receptors in health and disease.
    Weisman GA; Yu N; Liao Z; Gonzaléz F; Erb L; Seye CI
    Biotechnol Genet Eng Rev; 2006; 22():171-95. PubMed ID: 18476331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensory transduction of the ischemic myocardium.
    Ardell JL
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1753-4. PubMed ID: 20952672
    [No Abstract]   [Full Text] [Related]  

  • 13. Agonists and Antagonists for Purinergic Receptors.
    Müller CE; Baqi Y; Namasivayam V
    Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2 receptor stimulation induces amyloid precursor protein production and secretion in rat cortical astrocytes.
    Tran MD
    Neurosci Lett; 2011 Apr; 492(3):155-9. PubMed ID: 21300137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models.
    Haanes KA; Labastida-Ramírez A; Blixt FW; Rubio-Beltrán E; Dirven CM; Danser AH; Edvinsson L; MaassenVanDenBrink A
    Cephalalgia; 2019 Oct; 39(11):1421-1434. PubMed ID: 31104506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
    Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of purinergic signaling in cardiovascular diseases.
    Ralevic V; Burnstock G
    Drug News Perspect; 2003 Apr; 16(3):133-40. PubMed ID: 12819811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
    Horiuchi T; Dietrich HH; Hongo K; Dacey RG
    Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists.
    Lambrecht G; Braun K; Damer M; Ganso M; Hildebrandt C; Ullmann H; Kassack MU; Nickel P
    Curr Pharm Des; 2002; 8(26):2371-99. PubMed ID: 12369951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purinergic Receptors in Thrombosis and Inflammation.
    Hechler B; Gachet C
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2307-15. PubMed ID: 26359511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.